New Frontiers in Healthcare

ABOUT THE EVENT

New Frontiers in Healthcare 2026 explores how the UK and Switzerland can build on their world class life sciences foundations to deliver better health outcomes, drive economic growth, and reward the investment that makes innovation possible. 

Both countries have exceptional research institutions, deep talent pipelines, and proven translational capability. But strong foundations are not enough. Capital access, regulatory agility, and the conditions needed to attract and retain global investment all require attention. 

Under the theme “Innovation and Beyond: Delivering Health, Driving Growth, Rewarding Investment”, senior leaders will examine three interconnected challenges: removing the barriers to innovation, becoming a destination of choice for world class talent, and accelerating the path from innovation to adoption at scale. 

The emphasis is on practical insight, honest dialogue, and actionable collaboration. 

WHY NOW?

Healthcare systems globally face mounting pressure from demographic change, workforce constraints, rising costs, and persistent inequalities in outcomes. The UK and Switzerland are not immune.  

At the same time, the global life sciences landscape is shifting. New opportunities are emerging for ecosystems with the research strength, talent, and ambition to seize them.  

The question is not whether the UK and Switzerland can compete. It is whether they will create the conditions to do so.

CONTENT THEMES

Our 2026 programme combines impactuful keynotes, interactive speaker sessions, and issue-driven panel debates. Expect fresh thinking, practical take-aways, and a candid look at how policy, technology and macro-risk collide in today’s healthcare arena.

📌 Building a Globally Competitive European Life Sciences Ecosystem
The UK and Switzerland have become global life sciences leaders; this panel explores how they—and Europe more broadly—can strengthen their competitive edge by attracting and retaining world-class talent, capital, and innovation.
  

📌  Capital: Funding the Future of Life Sciences
Despite world-class science, the UK and Switzerland face growing competition for investment; this session explores how funding models, incentives, and capital markets can evolve to ensure breakthrough innovations are financed and scaled locally rather than abroad.

📌 Regulation: From Barrier to Competitive Advantage
Regulation can both safeguard patients and shape innovation; this session explores how the UK and Switzerland can turn regulatory excellence into a competitive advantage that attracts, rather than deters, life sciences investment and talent.

📌 Building an Ecosystem That Works for Patients, Populations, and Industry
Innovation only creates value if it reaches patients sustainably; this panel explores how pricing, reimbursement, and market access frameworks can support commercial success, reward breakthrough therapies, and keep life sciences investment anchored in Europe.

SPEAKER SESSIONS

📌 CAPITAL

📌 REGULATORY

📌 TALENT

EVENT HIGHLIGHTS

📌 Immerse yourself in insightful keynote addresses, engaging panel discussions, and interactive speaker sessions where industry experts delve into the hottest topics in healthcare and life sciences

📌 Network with a diverse community of conference delegates, speakers, and industry experts, forging meaningful connections that can drive your career and projects forward 

📌 Stay ahead of the curve and gain a leading edge in your field

SPEAKERS

LEAD SPONSOR

HOST

When

DETAILS 

Where

Planner

The British-Swiss Chamber of Commerce